© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Faropenem sodium didn't show up overnight. Back in the late 20th century, scientists in Japan set out to make safer, more powerful antibiotics because bacterial resistance kept rising. They built on the penem class, inspired by penicillins and carbapenems, tweaking the core bicyclic ring structure. Faropenem came to clinical notice due to its strong action against both Gram-positive and Gram-negative bacteria. In 1997, Japanese regulators approved its use, and ever since then, faropenem sodium has played a role in treatment options for infections that often outsmart older antibiotics.
Faropenem sodium usually appears as a white or slightly off-white powder. It’s marketed mostly as oral tablets or granules. Many brands, especially in Japan and India, have used it as a front-line treatment, often in the form of 200 mg tablets. Hospitals and clinics choose it because it hits a wide range of bugs that cause respiratory tract infections, urinary tract infections, and skin infections. There are products geared toward pediatric use, giving doctors another tool when children face stubborn bacteria.
Faropenem sodium packs some unique features. Chemically, it is a penem antibiotic with a molecular formula of C12H14N3NaO5S. Its structure contains a beta-lactam ring fused to a five-membered ring, with a sodium ion for stability and solubility. Faropenem sodium melts around 150–160°C. It dissolves well in water, which matters for dosing accuracy and for medication forms like syrups for children. In solid form, faropenem sodium maintains stability at room temperature, important for storage and transport. Over time, exposure to light and moisture can break it down, so packaging in air-tight, light-resistant containers helps keep it effective.
Manufacturers typically sell faropenem sodium under strict guidelines. Product labels must display its dose strength, batch number, manufacturing and expiry dates, and the country of origin. Quality control standards require specified purity—often above 98%—and checks for impurities like related substances and endotoxins. Pharmacopoeia standards set by regulatory bodies such as the Japanese Pharmacopoeia or Indian Pharmacopoeia explain required assay methods, storage instructions, and container types. These specifications serve consumers and pharmacists, making sure every dose delivers what it promises and nothing more.
Making faropenem sodium starts in the lab with assembling the penem skeleton from precursor compounds. Chemists use a step-wise approach, protecting sensitive groups and selectively reacting parts of the molecule to build up the complex structure. The sodium salt comes in by neutralizing the acidic form of faropenem with sodium hydroxide. Filtration and drying stages follow, where any unreacted bits and pieces get removed. Purification steps, like recrystallization, elevate the product to pharmaceutical grade. Every batch must pass authentication, often through chromatography and spectroscopy, to meet regulations and public health needs.
Faropenem sodium’s beta-lactam ring makes it active—but also fragile. Beta-lactamases, common bacterial enzymes, can break this ring and knock out the antibiotic’s power unless the structure resists such attacks. Chemists have worked to modify its chemical structure, adding groups that slow down this breakdown and make the drug resilient. They test various derivatives to see if stability or antibacterial punch improves. Most work in tweaking faropenem aims to blunt the edge of resistance, especially from tricky bacteria like ESBL-producing strains.
You might spot faropenem sodium by many names: Farom, Tripenem, or M-8264 show up on boxes in pharmacies, particularly in Asia. Chemists call it by its IUPAC handle: (5R,6S)-6-[(R)-1-Hydroxyethyl]-7-oxo-3-[(1Z)-2-oxo-1-(2-thienyl)ethylideneamino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium. These all track back to the same core molecule with tweaks for marketing or regional preference.
Safety around faropenem sodium extends from the lab to the clinic. Factory workers wear gloves, masks, and lab coats to avoid direct contact since beta-lactams can trigger allergies. Each batch goes through sterility checks and endotoxin assessment to guard against slipping contaminated doses onto the market. Doctors follow dosing guidelines based on age, kidney function, and infection severity. Regulators demand rigorous pharmacovigilance, meaning companies must report and monitor any unexpected side effects. Patients get leaflets warning about possible rashes or stomach upset and noting the need to complete the entire prescribed course.
Doctors reach for faropenem sodium to tackle stubborn infections—both in adults and kids. It’s used for everything from chronic bronchitis flare-ups and sinusitis to skin wounds and urinary tract complaints. Pediatricians in parts of Asia prescribe it for ear and throat infections that don’t budge with first-line drugs. Its oral forms give patients a break from injections, which matters for children and the elderly. Faropenem sodium remains a solid bet for outpatient therapy because people can swallow their dose at home.
Researchers keep testing faropenem sodium against new strains of bacteria and in different formulations. Teams in India and Japan have explored its synergy with other antibiotics, trying to punch through resistant bugs. Some work looks at nanoparticle carriers to improve how the drug is absorbed and how long it stays active in the system. There’s constant pressure from rising resistance rates, so scientists dig into the fine details—looking at how small chemical tweaks affect activity against evolving pathogens. Clinical trials monitor not just bacterial killing, but also how well patients recover, how the body handles the drug, and any hidden risks.
Any antibiotic, faropenem sodium included, can do harm if misused or wrongly prescribed. Toxicity research checks for adverse reactions across organs—especially liver and kidney function, since these clear most drugs. Animal studies pin down safe dose limits, while clinical use turns up rarer effects like allergic rashes or gastrointestinal problems. Pediatric dosing requires special caution, as children’s organs process drugs differently. Reports from clinics note that severe allergic reactions seem rare, but no drug is free from the possibility. Overuse risks breeding resistant bacteria, so part of toxicity research involves keeping an eye on public health patterns, not just lab numbers.
The world won’t be rid of antibiotic resistance anytime soon. Faropenem sodium still pulls its weight, but its long-term value depends on stewardship—prescribing only for clear bacterial infections and following the full treatment course. Ongoing research into new combinations and better delivery methods might stretch its usefulness. As more bugs fight back, faropenem-related compounds could find a bigger role in hospitals and clinics worldwide. Countries facing tough resistance patterns keep evaluating faropenem sodium for inclusion on essential medicine lists. Generics expand access, but continued monitoring ensures quality doesn’t slip. Looking ahead, ongoing surveillance and creative science stand as the main hope for keeping drugs like faropenem sodium part of the infection-fighting toolkit.
Faropenem sodium isn’t something you see lined up next to over-the-counter cough drops or painkillers. It belongs to a kind of antibiotics called beta-lactams, similar to penicillin or cephalosporins. Doctors turn to faropenem sodium when other meds fail to cover the tougher kinds of bacterial infections. Think about sinus infections that just won’t quit, pneumonia that keeps coming back, or urinary tract infections that pack a punch. In Japan and a handful of countries, this drug gives doctors another shot at beating back infections. I remember talking with a physician who appreciated how this antibiotic reached deep into tissue and covered a wider group of bacteria than the usual suspects.
A few years back, a relative of mine landed in the hospital with a chest infection that wouldn’t budge. The typical prescriptions didn’t work. The doctors had to check which antibiotics the bacteria still listened to. This is where faropenem sodium can step in, with its solid activity against common pathogens including Streptococcus pneumoniae and Haemophilus influenzae. Some research out of Asia found it helpful in children with middle ear infections, which can drag on and cause plenty of discomfort. It’s not the first pick in many countries, but it holds value when other drugs drop the ball.
We live in a world where antibiotics often lose steam. Some bacteria outsmart the drugs we trust, mainly because we overuse antibiotics or don’t finish them. Reports from the World Health Organization shape warnings about these superbugs that resist nearly everything in the toolkit. Faropenem sodium has held up better than some older antibiotics. Still, if we get careless, bacteria could start ignoring it too. That thought’s made me extra careful about demanding antibiotics for every cough or cold.
Not every country rolls out faropenem sodium at the pharmacy. Drug approval varies. The United States and much of Europe keep it off the shelves for now, citing concerns about resistance, cost, and the need for more safety data. Patients end up paying more for drugs like this out of pocket, sometimes traveling abroad or online. In Japan, where faropenem sodium’s available, doctors must balance benefits with the risk of encouraging more resistant bugs. It’s a tough call that asks health systems to weigh patient needs against long-term risks for everyone.
Antibiotics like faropenem sodium show the progress science can make. Yet no one pill clears all the problems linked to infection. Doctors listen to lab results, watch for resistance, and consider patient histories. Patients play a part too—by taking the full course and keeping antibiotics for real infections, not headaches or sore throats. We owe it to ourselves to keep antibiotics strong and reliable.
Faropenem sodium works as an antibiotic against many infections. As with most antibiotics, it helps fight bacteria, but sometimes it does more than just clear the infection. Over the years, those who’ve needed strong antibiotics have seen some familiar patterns in side effects. I find that knowing what to expect often takes away some of the anxiety linked to new medications.
Digestive problems top the list for people taking faropenem sodium. Nausea and loose stools hit about one in ten folks, sometimes making it tough to finish the treatment. Some feel their appetite slip or notice stomach gurgling that wasn't there before. I’ve watched family members on antibiotics struggle to keep down meals or have to plan life around bathroom trips, and it’s not a small thing. Research found that up to 13% of patients taking beta-lactam antibiotics like faropenem report these issues.
The gut hosts trillions of bacteria that keep digestion running smoothly. Antibiotics wipe out both good and bad bugs, tilting the whole system off balance. That’s why yogurt or probiotic-rich foods find their way into my fridge during a course like this—they can help get things back on track, although results vary person to person.
Rashes, itching, or redness rank high among the less common but more worrisome reactions. People with a history of penicillin allergies sometimes see similar symptoms with faropenem sodium. Medical data shows that up to 3% of patients using beta-lactam antibiotics face mild allergic symptoms. More rarely, serious allergic reactions like swelling of the lips or trouble breathing demand immediate attention. Anyone with a known allergy to cephalosporins or carbapenems should flag this to their doctor since cross-reactions sometimes occur.
Some patients have complained of headaches or dizziness during their course. These symptoms can mess with daily routines, especially for those needing to drive or work. Drug reports in Japan, where faropenem sodium gets prescribed more widely, mention these side effects in about 1 to 2% of cases. Staying hydrated and resting usually helps, but if the sensation sticks around, a call to the prescriber often clears things up.
A metallic taste in the mouth sometimes pops up. Kids may point out their food tastes funny, or adults find tea and coffee less enjoyable. A little fatigue or tiredness also appears in conversation with patients, though pinning that strictly on the medication proves tricky, especially because infection itself saps energy.
Lab results can show a mild increase in liver enzymes or changes in kidney function in rare cases. Doctors tend to keep an eye on anyone using this drug for several weeks, especially if there’s a medical history pointing that way. Regular bloodwork catches these changes early, letting a care team adjust the plan.
Clear guidance makes a big difference. I remind friends not to cut short any antibiotic course unless advised, and to jot down side effects as they show up—this record helps doctors fine-tune future treatments. Many community pharmacists now offer quick check-ins during and after antibiotic courses. Beyond that, sticking to only those antibiotics prescribed—and not sharing with family or friends—helps slow down the trend of superbugs and keeps these drugs working for everyone. If side effects get in the way, most doctors have backup options or tips for easing symptoms, so nobody should feel boxed in by a single prescription.
Faropenem sodium sits among the class of antibiotics called penems. Doctors often bring it out to treat infections caused by bacteria, especially in the lungs, urinary tract, skin, or sinuses. Antibiotic drugs ask for respect and care—mishandling can spark resistance and put people at risk down the line. Faropenem sodium stands out for tackling bacteria that have learned to dodge other medications. As people see more resistant infections in clinics and hospitals, taking antibiotics the right way matters even more.
If my doctor recommends faropenem sodium, I pay close attention to how and when I swallow each dose. The best result comes from sticking to the exact prescription—a detail people sometimes overlook. Doctors usually recommend swallowing the tablet after a meal. This helps the gut absorb the medicine and cuts down on stomach upset. Forgetting or skipping a meal and popping the pill anyway can lead to cramps or loose bowels; something I found out the tough way in my younger days as an impatient patient.
Water makes a difference too. I always reach for a big glass when it’s time for my pill. Chasing the tablet with just a sip leaves some medicine on the throat or esophagus, which doesn’t bode well for comfort.
One trap people fall into is stopping antibiotics because they feel better. That practice leads to more harm than good. Bacteria can regroup and come back meaner if the full course gets cut short. Doctors talk about this all the time; I’ve seen family members end up back in clinics with recurrences. It’s not just about feeling better—clearing bacteria takes the full duration, even when symptoms fade.
Missed doses present another real issue. Life gets in the way, alarms get ignored, or schedules shift, and suddenly, a dose goes missing. Experts recommend taking the missed tablet as soon as possible unless it’s nearly time for the next one. Doubling up does more harm than good, loading the body with too much medicine at once.
Anyone who’s ever experienced a drug allergy knows it can go from discomfort to emergency in a heartbeat. Faropenem falls into a group related to penicillins and cephalosporins. People with allergies to those shouldn’t touch faropenem without a doctor’s careful guidance. Rashes, trouble breathing, or swelling show up more often in sensitive folks. Reporting symptoms to a healthcare provider straight away saves trouble later.
Stomach trouble, loose motions, or headache sometimes enter the picture. Small side effects clear up on their own, but I don’t wait around if something seems off. Doctors rely on honest reporting to keep people safe.
Antibiotic use isn’t only a personal issue—it affects the community. Misusing faropenem sodium can give rise to superbugs, which threaten everyone. Each prescription carries responsibility. People can play a part by using prescriptions exactly as directed, saying no to sharing medication, and refusing to pressure doctors for unnecessary antibiotics.
Open conversation remains key. If a schedule doesn’t fit daily routines, talking it out with the doctor could prevent mistakes. Real health improvements happen through collaboration, honesty, and informed choices—far more than mindless pill-popping ever will.
Faropenem sodium caught the eye of many doctors and scientists for one reason—bacteria keep getting tougher to treat. This oral antibiotic belongs to the penem class, which has been used in various countries, mainly as a tool against infections that refuse to budge with older drugs. Drug resistance is not some far-off problem; ask any adult who’s been in a hospital and they’ll tell you about at least one story. My experience as a healthcare writer includes long conversations with infectious disease doctors who often mention the frustration over antibiotics that no longer work.
The stubbornness of bacteria didn’t just show up overnight. Decades of overusing antibiotics in coughs, sore throats, or animal feed led them to evolve. Tests like cultures and sensitivity panels show more Gram-negative organisms—think E. coli, Klebsiella—brushing off popular antibiotics that worked in the past. Hospitals end up with pathogens that scoff at beta-lactams, cephalosporins, even carbapenems in tough cases.
This is where Faropenem sodium steps up. Unlike some antibiotics, it can be taken by mouth and still tackle a range of bugs, including certain extended-spectrum beta-lactamase (ESBL) producers. Peer-reviewed research from Japan and India reports that Faropenem inhibits many ESBL-producing E. coli and Klebsiella strains—pathogens that frequently cause urinary tract and wound infections. In clinical settings, patients showed improvement when some classic antibiotics failed.
That said, some studies show mixed success against resistant strains of Pseudomonas and Acinetobacter. No single antibiotic solves every case. Clinical microbiology data highlight where Faropenem fits—it plugs gaps left by drugs like amoxicillin-clavulanate or cefixime, but does not sweep the field clean. Crucial in all this is the reminder: resistance patterns aren’t uniform across countries or even hospitals. Doctors lean heavily on sensitivity guides from their own labs, not anecdotes or early trial results.
Relying on Faropenem sodium comes with risk. Overuse and easy availability (as seen in several South Asian countries) threaten to put this drug on the same path as predecessors. Clinics sometimes hand it out for uncomplicated conditions, skipping basic diagnostics. The ugly result? Resistance starts to build, just as with fluoroquinolones before it.
Health systems can stretch the utility of Faropenem by limiting its prescription to cases backed by lab evidence. Stewardship programs, run by pharmacists and infectious disease experts, help keep antibiotics working by tracking how, when, and why they get used. This model stood out during my reporting at teaching hospitals in India and Singapore, where decision-making includes regular data reviews and open discussions about prescription patterns.
Everyone has a role in addressing resistance. Doctors can push for confirmatory cultures instead of guesswork. Pharmacists can flag repeated prescriptions. Drug regulators hold the power to restrict over-the-counter sales. It helps when patients ask questions about the drugs they’re given too. Reducing unnecessary use of Faropenem and other broad-spectrum antibiotics will keep more tools in the kit for the next public health crisis.
New antibiotics remain scarce. Protecting those that still work, like Faropenem sodium, buys precious time while research teams hunt for new solutions.
Faropenem sodium works as an oral antibiotic, often called on for certain infections where common treatments like amoxicillin or cephalosporins may not help. Doctors appreciate its broad-spectrum reach, knocking back everything from skin infections to complicated urinary tract troubles. For patients who’ve encountered one too many courses of older antibiotics, faropenem feels like a breath of fresh air.
One fact stands tall: not everyone can walk into a pharmacy and safely pick up this drug. If someone has ever had an allergic reaction to penicillin, cephalosporins, or other carbapenems, the risk is too high to ignore. I remember a friend with penicillin allergy who nearly landed in the ER after his doctor prescribed a related medicine by mistake. Cross-allergy can spark everything from rashes to full-blown anaphylaxis.
Some people with severe kidney conditions face bigger risks because faropenem travels out of the body through the kidneys. If the filter’s clogged, the drug can hang around longer than expected and raise chances of toxicity. Regular blood tests and dose adjustments help, but skipping this step can spell trouble, especially for older adults with more fragile kidneys.
Mixing faropenem with certain anticonvulsants (like valproic acid) drops effectiveness fast. Blood levels of valproic acid drop, risking more seizures. Managing this isn’t as simple as telling people to "be careful;" patients and doctors need honest conversations. Pharmacists can run a medication review to check for nasty combinations hiding in the background.
Mix-ups don’t end there. Faropenem sometimes tugs at the gut flora, which opens the door to antibiotic-associated diarrhea. In rare cases, the bacteria Clostridioides difficile can surge, causing dangerous colitis. Hospitals everywhere wrestle with this issue. I’ve talked to several infectious disease doctors who have seen patients bounce back from one infection, only to end up with a stubborn, recurrent gut infection.
Pregnant women have extra to think about since faropenem doesn’t come with years of human safety data. While animal studies don’t raise big red flags, doctors lean on caution, focusing on proven antibiotics first unless the options run thin. Nursing moms need wisdom, too, since there’s not enough information about how much medicine ends up in breast milk and what that means for babies.
For kids, especially toddlers, safety checks matter even more. Pediatric dosing requires a careful hand; too high and you risk side effects, too low and infections can dig in deeper. Many pediatricians reach for alternatives unless absolutely necessary.
Nobody expects antibiotics to work miracles without risks. Still, smarter prescribing makes a difference. Electronic medical records can flag allergies and dangerous combinations before prescriptions go out. Regular patient follow-up helps pick up early signs of trouble. Health providers can update their knowledge through continued education, which pays off when drugs like faropenem become necessary.
As antibiotic resistance rises, more people will hear about faropenem and drugs like it. The need for careful decision-making only gets stronger. With honest conversations and close monitoring, patients and doctors can get the best from new treatments, without letting safety slip through the cracks.
| Names | |
| Preferred IUPAC name | sodium (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-7-oxo-3-[(S)-2-oxo-1-(tetrahydro-2H-pyran-3-yl)ethyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate |
| Other names |
Farom Faropenem Faropenem Na Orapem Tripenem Y-9409 |
| Pronunciation | /fɑːˈrəʊ.pə.nɛm ˈsəʊ.di.əm/ |
| Identifiers | |
| CAS Number | 122547-55-3 |
| Beilstein Reference | 4142916 |
| ChEBI | CHEBI:5972 |
| ChEMBL | CHEMBL2103830 |
| ChemSpider | 113476 |
| DrugBank | DB13931 |
| ECHA InfoCard | 03a5a879-b7e4-4e35-96c0-0ea9d3c135b2 |
| EC Number | 65058-48-6 |
| Gmelin Reference | 94220 |
| KEGG | D04558 |
| MeSH | D000077325 |
| PubChem CID | 10184620 |
| RTECS number | UZ7S028309 |
| UNII | 2X40W20848 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C12H14N2NaO5S |
| Molar mass | 307.284 g/mol |
| Appearance | White to pale yellowish white crystalline powder |
| Odor | Odorless |
| Density | 1.8 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -0.82 |
| Acidity (pKa) | 3.2 |
| Basicity (pKb) | 5.4 |
| Magnetic susceptibility (χ) | -78.2×10⁻⁶ cm³/mol |
| Dipole moment | 2.98 D |
| Pharmacology | |
| ATC code | J01DI03 |
| Hazards | |
| Main hazards | May cause respiratory irritation. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS07, GHS08, Warning, H302, H361, P264, P270, P308+P313, P405, P501 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Store at 20° to 25°C (68° to 77°F). Protect from light and moisture. Use only as directed by a physician. |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Lethal dose or concentration | LD50 (oral, mouse): >4,000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Faropenem Sodium: ">2000 mg/kg (oral, rat) |
| NIOSH | Not Listed |
| PEL (Permissible) | 0.1 mg/m³ |
| REL (Recommended) | 300 mg daily |
| Related compounds | |
| Related compounds |
Faropenem Faropenem medoxomil Meropenem Ertapenem Imipenem Doripenem Biapenem Panipenem Tebipenem Razupenem |
